Valterra Resource Corporation Reports Sampling Results of up to 28.1% Cg from Bobcaygeon Discovery Zone
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ